British Journal of Clinical Pharmacology

Interim analyses in clinical trials
pp. 393-393(1)
Authors: Whitehead, John; Todd, Susan; Whitehead, Anne; Stallard, Nigel

Interim analyses and sequential designs in phase III studies
pp. 394-399(6)
Authors: Todd, Susan; Whitehead, Anne; Stallard, Nigel; Whitehead, John

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
pp. 400-409(10)
Authors: Daley-Yates, Peter T.; Price, Alison C.; Sisson, Jonathan R.; Pereira, Adrian; Dallow, Nigel

Influence of cirrhosis on lamotrigine pharmacokinetics
pp. 410-414(5)
Authors: Marcellin, P.; de Bony, F.; Garret, C.; Altman, C.; Boige, V.; Castelnau, C.; Laurent-Puig, P.; Trinchet, J. C.; Rolan, P.; Chen, C.; Mamet, J. P.; Bidault, R.

Dopamine D₂-like receptors and amino acid-induced glomerular hyperfiltration in humans
pp. 415-421(7)
Authors: Luippold, Gerd; Schneider, Swetlana; Stefanescu, Andreea; Benöhr, Peter; Mühlbauer, Bernd

Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects
pp. 423-428(6)
Authors: de Visser, S. J.; van Gerven, J. M. A.; Schoemaker, R. C.; Cohen, A. F.

The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers
pp. 429-435(7)
Authors: Yates, R. A.; Wong, J.; Seiberling, M.; Merz, M.; März, W.; Nauck, M.

Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans
pp. 437-441(5)
Authors: Fleishaker, Joseph C.; Ryan, Kristi K.; Jansat, Josep M.; Carel, Barabara J.; Bell, David J. A.; Burke, Moira T.; Azie, Nkechi E.

Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects
pp. 443-450(8)
Authors: Lebrun-Vignes, B.; Archer, V. Corbrion; Diquet, B.; Levron, J. C.; Chosidow, O.; Puech, A. J.; Warot, D.

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
pp. 451-460(10)
Authors: Johnson, Trevor N.; Tanner, M. Stuart; Taylor, Christopher J.; Tucker, Geoffrey T.

Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes
pp. 461-470(10)
Authors: Yeo, Karen Rowland; Yeo, Wilfred W.

Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse events
pp. 471-474(4)
Authors: Tamminga, Wim J.; Wemer, Johan; Oosterhuis, Berend; Wieling, Jaap; Touw, Daan J.; de Zeeuw, Rokus A.; de Leij, Lou F. M. H.; Jonkman, Jan H. G.

Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus
pp. 475-477(3)
Authors: Kubota, T.; Chiba, K.

Quinapril and its metabolite quinaprilat in human milk
pp. 478-481(4)
Authors: Begg, E. J.; Robson, R. A.; Gardiner, S. J.; Hudson, L. J.; Reece, P. A.; Olson, S. C.; Posvar, E. L.; Sedman, A. J.

Influence of ACE-inhibition on salt-mediated worsening of pulmonary gas exchange in heart failure
pp. 482-487(6)
Authors: Guazzi, Marco; Brambilla, Roberto; Agostoni, Piergiuseppe; Guazzi, Maurizio D.

Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases
pp. 489-490(2)
Authors: Fourrier, Annie; Bégaud, Bernard; Alpérovitch, Annick; Verdier-Taillefer, Marie-Hélène; Touzé, Emmanuel; Decker, Nicole; Imbs, Jean-Louis

A textbook of clinical pharmacology
pp. 491-492(2)
Author: Ford, G. A.

Drug interactions and infectious diseases
pp. 491-492(2)
Author: Shenfield, Gillian M.